-

HCA Healthcare to Host 2023 Investor Day

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced the Company will host its 2023 Investor Day with analysts and institutional investors on Thursday, November 9, 2023, beginning at 8:00 a.m. CT.

A team of HCA Healthcare leaders will offer perspectives on the Company’s financial performance, operations, and strategies to drive growth and create value. In conjunction with Investor Day, the Company plans to provide early perspectives on the outlook for 2024 and longer-term financial targets.

The Company will stream the presentations and the management question and answer portion of Investor Day and will make conference materials available on its Investor Relations page (https://investor.hcahealthcare.com/events-and-presentations/default.aspx) at approximately 6:30 a.m. CT on November 9, 2023. Investor Day is expected to conclude at approximately 3:45 p.m. CT. A replay will be available on the Company website beginning Friday, November 10, 2023, at 4:00 p.m. CT.

About the Company

As of September 30, 2023, HCA Healthcare operated 183 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

Industry:

HCA Healthcare

NYSE:HCA
Release Versions
English

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

More News From HCA Healthcare

HCA Healthcare, Inc. to Present at September Conferences

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com. Dates and tim...

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a...

HCA Healthcare Reports Second Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview. Key second quarter metrics (all percentage changes compare 2Q 2026 to 2Q 2025 unless otherwise noted): Revenues increased 8.7 percent to $20.230 billion Net income attributable...
Back to Newsroom